<産業資料/調査レポートの題名> 2022年6月19日

同種幹細胞の世界市場:種類別、地域別


◆英文タイトル:Allogeneic Stem Cells Market by Application and Geography - Forecast and Analysis 2020-2024

PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
• 2.1 Preface
• 2.2 Preface
• 2.3 Currency conversion rates for US$
PART 03: MARKET LANDSCAPE
• Market ecosystem
• Market characteristics
• Market segmentation analysis
• Value Chain Analysis
PART 04: MARKET SIZING
• Market definition
• Market sizing 2019
• Market size and forecast 2019-2024
• Market Outlook
PART 05: FIVE FORCES ANALYSIS
• Bargaining power of buyers
• Bargaining power of suppliers
• Threat of new entrants
• Threat of substitutes
• Threat of rivalry
• Market condition
PART 06: MARKET SEGMENTATION BY APPLICATION
• Market segmentation by application
• Comparison by application
• Regenerative therapy – Market size and forecast 2019-2024
• Drug discovery and development – Market size and forecast 2019-2024
• Market opportunity by application
PART 07: CUSTOMER LANDSCAPE
PART 08: GEOGRAPHIC LANDSCAPE
• Geographic segmentation
• Geographic comparison
• North America – Market size and forecast 2019-2024
• Europe – Market size and forecast 2019-2024
• Asia – Market size and forecast 2019-2024
• ROW – Market size and forecast 2019-2024
• Key leading countries
• Market opportunity
PART 09: DECISION FRAMEWORK
PART 10: DRIVERS AND CHALLENGES
• Market drivers
• Market challenges
PART 11: MARKET TRENDS
• Rising awareness of stem cells
• Increasing R&D activities in stem cell therapy
• Special drug designations
PART 12: VENDOR LANDSCAPE
• Overview
• Landscape disruption
• Competitive scenario
PART 13: VENDOR ANALYSIS
• Vendors covered
• Vendor classification
• Market positioning of vendors
• Biosolution Co. Ltd.
• Cynata Therapeutics Ltd.
• JCR Pharmaceuticals Co. Ltd.
• Lineage Cell Therapeutics Inc.
• MEDIPOST Co. Ltd.
• MiMedx Group Inc.
• Osiris Therapeutics Inc.
• Stempeutics Research Pvt. Ltd.
• Takeda Pharmaceutical Co. Ltd.
PART 14: APPENDIX
• Research methodology
• List of abbreviations
• Definition of market positioning of vendors
PART 15: EXPLORE TECHNAVIO


Exhibit 01: Global pharmaceuticals market
Exhibit 02: Segments of global pharmaceuticals market
Exhibit 03: Market characteristics
Exhibit 04: Market segments
Exhibit 05: Vendor key offerings
Exhibit 06: Market definition – Inclusions and exclusions checklist
Exhibit 07: Market size 2019
Exhibit 08: Global market: Size and forecast 2019-2024 ($ millions)
Exhibit 09: Global market: Year-over-year growth 2020-2024 (%)
Exhibit 10: Five forces analysis 2019
Exhibit 11: Five forces analysis 2024
Exhibit 12: Bargaining power of buyers
Exhibit 13: Bargaining power of suppliers
Exhibit 14: Threat of new entrants
Exhibit 15: Threat of substitutes
Exhibit 16: Threat of rivalry
Exhibit 17: Market condition – Five forces 2019
Exhibit 18: Application – Market share 2019-2024 (%)
Exhibit 19: Comparison by application
Exhibit 20: Regenerative therapy – Market size and forecast 2019-2024 ($ millions)
Exhibit 21: Regenerative therapy – Year-over-year growth 2020-2024 (%)
Exhibit 22: Drug discovery and development – Market size and forecast 2019-2024 ($ millions)
Exhibit 23: Drug discovery and development – Year-over-year growth 2020-2024 (%)
Exhibit 24: Market opportunity by application
Exhibit 25: Customer landscape
Exhibit 26: Market share by geography 2019-2024 (%)
Exhibit 27: Geographic comparison
Exhibit 28: North America – Market size and forecast 2019-2024 ($ millions)
Exhibit 29: North America – Year-over-year growth 2020-2024 (%)
Exhibit 30: Europe – Market size and forecast 2019-2024 ($ millions)
Exhibit 31: Europe – Year-over-year growth 2020-2024 (%)
Exhibit 32: Asia – Market size and forecast 2019-2024 ($ millions)
Exhibit 33: Asia – Year-over-year growth 2020-2024 (%)
Exhibit 34: ROW – Market size and forecast 2019-2024 ($ millions)
Exhibit 35: ROW – Year-over-year growth 2020-2024 (%)
Exhibit 36: Key leading countries
Exhibit 37: Market opportunity
Exhibit 38: New product approvals
Exhibit 39: Complications associated with stem cell therapies
Exhibit 40: Impact of drivers and challenges
Exhibit 41: Drug designations
Exhibit 42: Vendor landscape
Exhibit 43: Landscape disruption
Exhibit 44: Vendors covered
Exhibit 45: Vendor classification
Exhibit 46: Market positioning of vendors
Exhibit 47: Biosolution Co. Ltd. – Vendor overview
Exhibit 48: Biosolution Co. Ltd. – Business segments
Exhibit 49: Biosolution Co. Ltd. – Key offerings
Exhibit 50: Cynata Therapeutics Ltd. – Vendor overview
Exhibit 51: Cynata Therapeutics Ltd. – Business segments
Exhibit 52: Cynata Therapeutics Ltd. – Organizational developments
Exhibit 53: Cynata Therapeutics Ltd. – Key offerings
Exhibit 54: JCR Pharmaceuticals Co. Ltd. – Vendor overview
Exhibit 55: JCR Pharmaceuticals Co. Ltd. – Business segments
Exhibit 56: JCR Pharmaceuticals Co. Ltd. – Segment focus
Exhibit 57: JCR Pharmaceuticals Co. Ltd. – Key offerings
Exhibit 58: Lineage Cell Therapeutics Inc. – Vendor overview
Exhibit 59: Lineage Cell Therapeutics Inc. – Business segments
Exhibit 60: Lineage Cell Therapeutics Inc. – Geographic focus
Exhibit 61: Lineage Cell Therapeutics Inc. – Key offerings
Exhibit 62: MEDIPOST Co. Ltd. – Vendor overview
Exhibit 63: MEDIPOST Co. Ltd. – Business segments
Exhibit 64: MEDIPOST Co. Ltd. – Organizational developments
Exhibit 65: MEDIPOST Co. Ltd. – Key offerings
Exhibit 66: MiMedx Group Inc. – Vendor overview
Exhibit 67: MiMedx Group Inc. – Business segments
Exhibit 68: MiMedx Group Inc. – Organizational developments
Exhibit 69: MiMedx Group Inc. – Key offerings
Exhibit 70: Osiris Therapeutics Inc. – Vendor overview
Exhibit 71: Osiris Therapeutics Inc. – Business segments
Exhibit 72: Osiris Therapeutics Inc. – Organizational developments
Exhibit 73: Osiris Therapeutics Inc. – Key offerings
Exhibit 74: Stempeutics Research Pvt. Ltd. – Vendor overview
Exhibit 75: Stempeutics Research Pvt. Ltd. – Product segments
Exhibit 76: Stempeutics Research Pvt. Ltd. – Key offerings
Exhibit 77: Takeda Pharmaceutical Co. Ltd. – Vendor overview
Exhibit 78: Takeda Pharmaceutical Co. Ltd. – Business segments
Exhibit 79: Takeda Pharmaceutical Co. Ltd. – Organizational developments
Exhibit 80: Takeda Pharmaceutical Co. Ltd. – Geographic focus
Exhibit 81: Takeda Pharmaceutical Co. Ltd. – Key offerings
Exhibit 82: Validation techniques employed for market sizing
Exhibit 83: Definition of market positioning of vendors


LINEで送る
Share on LinkedIn
このエントリーをはてなブックマークに追加
Bookmark this on BuzzURL
Bookmark this on Yahoo Bookmark